Related Experiment Videos
[Complete minimally invasive Ivor-Lewis esophageal resection]
Summary
Minimally invasive Ivor Lewis esophagectomy with intrathoracic anastomosis is a safe and feasible option for esophageal cancer treatment. This thoracolaparoscopic approach demonstrated no postoperative mortality and manageable complications.
Area of Science:
- Surgical Oncology
- Minimally Invasive Surgery
Background:
- Minimally invasive esophagectomy is increasingly adopted for esophageal cancer.
- The Ivor Lewis esophagectomy technique is being adapted for minimally invasive approaches.
Purpose of the Study:
- To analyze technical difficulties and intraoperative complications of thoracolaparoscopic Ivor Lewis esophagectomy with intrathoracic anastomosis.
- To evaluate postoperative complications using the Clavien-Dindo classification.
Main Methods:
- Retrospective analysis of 19 patients undergoing completely minimally invasive esophagectomy.
- Inclusion criterion: history of thoracolaparoscopic esophagectomy.
- Multidisciplinary approach for diagnosis, surgical indication, and perioperative care.
Main Results:
- 19 patients (13 male, 6 female) with adenocarcinoma underwent the procedure.
- Postoperative morbidity was 68.4%, with Grade III complications (36.8%) being most frequent.
- Anastomotic leak was the most severe complication, managed with vacuum therapy and stenting. No postoperative mortality.
- Mean hospital stay was 12 days; mean ICU stay was 3.6 days.
Conclusions:
- Thoracolaparoscopic Ivor Lewis esophagectomy with intrathoracic anastomosis is a feasible and accessible option.
- The procedure appears safe regarding technical challenges and short-term/long-term complications.
- Oncosurgical principles of radicality, functionality, safety, and cost-effectiveness must be maintained.